PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells
- PMID: 20103619
- PMCID: PMC2890071
- DOI: 10.1158/0008-5472.CAN-09-4043
PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells
Abstract
Melanoma differentiation associated gene-7(mda-7) encodes IL-24, a cytokine that can selectively trigger apoptosis in transformed cells. Recombinant mda-7 adenovirus (Ad.mda-7) effectively kills glioma cells, offering a novel gene therapy strategy to address deadly brain tumors. In this study, we defined the proximal mechanisms by which Ad-mda-7 kills glioma cells. Key factors implicated included activation of the endoplasmic reticulum stress kinase protein kinase R-like endoplasmic reticulum kinase (PERK), Ca(++) elevation, ceramide generation and reactive oxygen species (ROS) production. PERK inhibition blocked ceramide or dihydroceramide generation, which were critical for Ca(++) induction and subsequent ROS formation. Activation of autophagy and cell death relied upon ROS formation, the inhibition of which ablated Ad.mda-7-killing activity. In contrast, inhibiting TRX induced by Ad.MDA-7 enhanced tumor cytotoxicity and improved animal survival in an orthotopic tumor model. Our findings indicate that mda-7/IL-24 induces an endoplasmic reticulum stress response that triggers production of ceramide, Ca(2+), and ROS, which in turn promote glioma cell autophagy and cell death.
Conflict of interest statement
No potential conflicts of interest were disclosed.
Figures
Similar articles
-
OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins.Cancer Biol Ther. 2010 Apr 1;9(7):526-36. doi: 10.4161/cbt.9.7.11116. Epub 2010 Apr 1. Cancer Biol Ther. 2010. PMID: 20107314 Free PMC article.
-
MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism.Mol Cancer Ther. 2009 May;8(5):1280-91. doi: 10.1158/1535-7163.MCT-09-0073. Epub 2009 May 5. Mol Cancer Ther. 2009. PMID: 19417161 Free PMC article.
-
A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.Mol Pharmacol. 2011 Mar;79(3):368-80. doi: 10.1124/mol.110.069484. Epub 2010 Nov 30. Mol Pharmacol. 2011. PMID: 21119025 Free PMC article.
-
MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.Anticancer Drugs. 2010 Sep;21(8):725-31. doi: 10.1097/CAD.0b013e32833cfbe1. Anticancer Drugs. 2010. PMID: 20613485 Free PMC article. Review.
-
The development of MDA-7/IL-24 as a cancer therapeutic.Pharmacol Ther. 2010 Nov;128(2):375-84. doi: 10.1016/j.pharmthera.2010.08.001. Epub 2010 Aug 21. Pharmacol Ther. 2010. PMID: 20732354 Free PMC article. Review.
Cited by
-
Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.Semin Cancer Biol. 2020 Nov;66:140-154. doi: 10.1016/j.semcancer.2019.07.013. Epub 2019 Jul 26. Semin Cancer Biol. 2020. PMID: 31356866 Free PMC article. Review.
-
Autophagy paradox and ceramide.Biochim Biophys Acta. 2014 May;1841(5):783-92. doi: 10.1016/j.bbalip.2013.09.005. Epub 2013 Sep 19. Biochim Biophys Acta. 2014. PMID: 24055889 Free PMC article. Review.
-
Unconventional Protein Secretion in Brain Tumors Biology: Enlightening the Mechanisms for Tumor Survival and Progression.Front Cell Dev Biol. 2022 Jun 15;10:907423. doi: 10.3389/fcell.2022.907423. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35784465 Free PMC article. Review.
-
Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.Mol Pharmacol. 2013 Aug;84(2):171-81. doi: 10.1124/mol.113.086553. Epub 2013 May 9. Mol Pharmacol. 2013. PMID: 23661648 Free PMC article.
-
Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling.Cancer Biol Ther. 2012 Jul;13(9):793-803. doi: 10.4161/cbt.20562. Epub 2012 Jun 7. Cancer Biol Ther. 2012. PMID: 22673740 Free PMC article.
References
-
- Robins HI, Chang S, Butowski N, Mehta M. Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr Oncol Rep. 2007;9:66–70. - PubMed
-
- Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene. 1995;11:2477–86. - PubMed
-
- Ekmekcioglu S, Ellerhorst J, Mhashilkar AM, et al. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer. 2001;94:54–9. - PubMed
-
- Ellerhorst JA, Prieto VG, Ekmekcioglu S. Loss of MDA-7 expression with progression of melanoma. J Clin Oncol. 2002;20:1069–74. - PubMed
-
- Huang EY, Madireddi MT, Gopalkrishnan RV, et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene. 2001;20:7051–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA108520/CA/NCI NIH HHS/United States
- P01-NS031492/NS/NINDS NIH HHS/United States
- R01-CA098712/CA/NCI NIH HHS/United States
- R01 CA063753/CA/NCI NIH HHS/United States
- P01 CA097132/CA/NCI NIH HHS/United States
- R01 CA122930-03/CA/NCI NIH HHS/United States
- P01 CA097132-070004/CA/NCI NIH HHS/United States
- R01 DK052825-11/DK/NIDDK NIH HHS/United States
- P01 CA104177/CA/NCI NIH HHS/United States
- R01 CA088932-09/CA/NCI NIH HHS/United States
- R01-CA77141/CA/NCI NIH HHS/United States
- R01 CA098712/CA/NCI NIH HHS/United States
- R01 DE016572-05/DE/NIDCR NIH HHS/United States
- R01 CA088932/CA/NCI NIH HHS/United States
- P01-CA104177/CA/NCI NIH HHS/United States
- P01 NS031492/NS/NINDS NIH HHS/United States
- R01-CA63753/CA/NCI NIH HHS/United States
- R01 CA134721/CA/NCI NIH HHS/United States
- R01-DK52825/DK/NIDDK NIH HHS/United States
- P01 CA104177-01A20002/CA/NCI NIH HHS/United States
- R01 CA122930/CA/NCI NIH HHS/United States
- R01 CA097318/CA/NCI NIH HHS/United States
- R01-CA108325/CA/NCI NIH HHS/United States
- R01 CA108520-05/CA/NCI NIH HHS/United States
- R01 DK052825/DK/NIDDK NIH HHS/United States
- R01-CA097318/CA/NCI NIH HHS/United States
- R01 DE016572/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous